Grim Reaper ends cancer drug study
If you think approved drugs are bad, you should see the junk that never makes it to the pharmacy.
In the latest outrage, Pfizer was forced to cut short a clinical trial on a lung cancer drug called figitumumab. Officially, it's because they decided the med wouldn't improve survival among lung cancer patients.
Unofficially, it's because the test patients were dropping like flies.
Seems like a good reason to ditch this experimental drug and start from square one. But not Pfizer! Despite the disastrous results of the lung cancer trial, Pfizer is continuing to test this drug on patients with breast and prostate cancer.
I wonder if their blatant disregard for the lives of their test subjects has anything to do with this little tidbit I read in The Wall Street Journal: Analysts estimate that if the drug is approved, it could bring in $1 billion in sales by 2015.
Pfizer has one billion reasons to press on with their dangerous experiments -- so who cares if a handful of people die in the process?
I can't help but wonder why people are willing to be Big Pharma's guinea pigs in the first place. I imagine it's because they think they've run out of options -- especially if they've been diagnosed with cancer. But if that's the case, then they've bought into the lie.
No matter what mainstream medicine tells you, there are real alternatives out there that don't involve subjecting yourself to chemotherapy or experimental drugs.
If you're worried about cancer, do yourself a favor and take a look at my special report,
"Deadly Cancer Myths – and the Truth That Will Save Your Life."
You'll be stunned at what the mainstream is keeping from you.
Busting mainstream myths,
William Campbell Douglass II, M.D. 
